Stock Track | UltraGreen.ai Soars 3.50% Intraday on Analyst View It's Shielded from Pharma Tariffs

Stock Track
04/07

ULTRAGREEN AI USD (ULG.SI) saw its stock price soar by 3.50% during intraday trading on Tuesday.

The surge follows analysis from DBS Group Research suggesting the company is unlikely to be negatively impacted by the Trump administration's decision to impose a 100% tariff on patented pharmaceutical products. The firm's water-soluble, FDA-approved dye used for fluorescence imaging is classified as a generic drug and falls under the current tariff exemption.

Analysts added that demand for the product is expected to remain relatively price-inelastic, and the company should be able to pass on any potential future tariff-related costs to customers. An additional mitigating factor is that UltraGreen.ai's kits for the Americas are packaged in Michigan. DBS maintains its buy rating and a US$2.00 target price for the stock.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10